Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Return on Assets (2016 - 2025)

Viridian Therapeutics, Inc.\DE has reported Return on Assets over the past 12 years, most recently at 0.46% for Q4 2025.

  • Quarterly results put Return on Assets at 0.46% for Q4 2025, down 11.0% from a year ago — trailing twelve months through Dec 2025 was 0.46% (down 11.0% YoY), and the annual figure for FY2025 was 0.42%, up 2.0%.
  • Return on Assets for Q4 2025 was 0.46% at Viridian Therapeutics, Inc.\DE, up from 0.52% in the prior quarter.
  • Over the last five years, Return on Assets for VRDN hit a ceiling of 0.3% in Q4 2022 and a floor of 1.1% in Q2 2021.
  • Median Return on Assets over the past 5 years was 0.45% (2022), compared with a mean of 0.53%.
  • Peak annual rise in Return on Assets hit 98bps in 2021, while the deepest fall reached -38bps in 2021.
  • Viridian Therapeutics, Inc.\DE's Return on Assets stood at 0.37% in 2021, then rose by 21bps to 0.3% in 2022, then crashed by -96bps to 0.58% in 2023, then skyrocketed by 39bps to 0.36% in 2024, then fell by -30bps to 0.46% in 2025.
  • The last three reported values for Return on Assets were 0.46% (Q4 2025), 0.52% (Q3 2025), and 0.55% (Q2 2025) per Business Quant data.